ArticleInflammopharmacology2018

Pharmacological inhibition of the NLRP3 inflammasome as a potential target for multiple sclerosis induced central neuropathic pain.

Nemat Khan et al.PubMed ↗Publisher ↗

No numbers read from the abstract.